Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith F Tipton

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Cellular and Molecular Life Sciences : CMLS|May 3, 2011
Highly reactive oxygen species: detection, formation, and possible functionsWolfhardt Freinbichler, Maria A Colivicchi, Chiara Stefanini, et al.
The Biochemical Journal|April 1, 2005
Structure-activity studies with high-affinity inhibitors of pyroglutamyl-peptidase IIJulie A Kelly, Gaia A Scalabrino, Gillian R Slator, et al.
Frontiers in Neuroscience|December 10, 2016
Monoaminergic and Histaminergic Strategies and Treatments in Brain DiseasesGiuseppe Di Giovanni, Dubravka Svob Strac, Montse Sole, et al.
Journal of Cell Science|October 2, 2014
Galactosyltransferase 4 is a major control point for glycan branching in N-linked glycosylationAndrew G McDonald, Jerrard M Hayes, Tania Bezak, et al.
Neuropharmacology|April 10, 2007
Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormoneGaia A Scalabrino, Nicola Hogan, Kathy M O'Boyle, et al.
The FEBS Journal|March 3, 2018
STRENDA DB: enabling the validation and sharing of enzyme kinetics dataNeil Swainston, Antonio Baici, Barbara M Bakker, et al.
The FEBS Journal|March 5, 2026
Metabolic thermodynamics: pertinent reference state and energy potentialsHans V Westerhoff, Barbara M Bakker, Andreas S Bommarius, et al.
Neuropharmacology|October 5, 2014
First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative modelsJulie A Kelly, Noreen T Boyle, Natalie Cole, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Cellular and Molecular Life Sciences : CMLS|May 3, 2011
Highly reactive oxygen species: detection, formation, and possible functionsWolfhardt Freinbichler, Maria A Colivicchi, Chiara Stefanini, et al.
The Biochemical Journal|April 1, 2005
Structure-activity studies with high-affinity inhibitors of pyroglutamyl-peptidase IIJulie A Kelly, Gaia A Scalabrino, Gillian R Slator, et al.
Frontiers in Neuroscience|December 10, 2016
Monoaminergic and Histaminergic Strategies and Treatments in Brain DiseasesGiuseppe Di Giovanni, Dubravka Svob Strac, Montse Sole, et al.
Journal of Cell Science|October 2, 2014
Galactosyltransferase 4 is a major control point for glycan branching in N-linked glycosylationAndrew G McDonald, Jerrard M Hayes, Tania Bezak, et al.
Neuropharmacology|April 10, 2007
Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormoneGaia A Scalabrino, Nicola Hogan, Kathy M O'Boyle, et al.
The FEBS Journal|March 3, 2018
STRENDA DB: enabling the validation and sharing of enzyme kinetics dataNeil Swainston, Antonio Baici, Barbara M Bakker, et al.
The FEBS Journal|March 5, 2026
Metabolic thermodynamics: pertinent reference state and energy potentialsHans V Westerhoff, Barbara M Bakker, Andreas S Bommarius, et al.
Neuropharmacology|October 5, 2014
First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative modelsJulie A Kelly, Noreen T Boyle, Natalie Cole, et al.
Pageof 6